Table 1 DNA methylation (%) in the FCGRT locus before and after Aza treatment.
From: Contribution of DNA methylation to the expression of FCGRT in human liver and myocardium
Cell line | CpG sites in −1021 to −842 bp region | CpG sites in −707 to −628 bp region | CpG sites in −1021 to −628 bp region | ||||||
|---|---|---|---|---|---|---|---|---|---|
Basal | 5 µM Aza 72 h | 5 µM Aza 120 h | Basal | 5 µM Aza 72 h | 5 µM Aza 120 h | Basal | 5 µM Aza 72 h | 5 µM Aza 120 h | |
AC16 | 25 ± 28% | 9 ± 12% | 0 ± 0% | 46 ± 22% | 41 ± 27% | 21 ± 9% | 35 ± 27% | 24 ± 26% | 10 ± 12% |
Hep G2 | 0 ± 0% | 0 ± 0% | 0 ± 0% | 7 ± 17% | 0 ± 0% | 0 ± 0% | 3 ± 12% | 0 ± 0% | 0 ± 0% |
SNU-475 | 84 ± 17% | 69 ± 27% | 0 ± 0% | 80 ± 19% | 82 ± 19% | 32 ± 17% | 83 ± 18% | 75 ± 25% | 15 ± 20% |
